Kid's BMI at 10 predicts diabetes risk? Here’s what the genetics study says

A child’s Body Mass Index (BMI) at age 10 and their subsequent growth trajectory through age 18 are critical indicators of future metabolic health, according to a new study mapping the genetic architecture of physical development.

The research, published in the journal Nature Communications, suggests these two factors are more strongly correlated with the eventual risk of developing type 2 diabetes, high cholesterol, and heart disease in adulthood. Nicole Warrington, a senior research fellow at the University of Queensland and the study’s lead author, noted that the findings offer a deeper look into the biological foundations of childhood growth.

"We found that about one quarter of the differences in how children's body weight changes from age one to 18 years is due to genetics," Warrington said. She added that the data "indicates that we are ignoring important information when assessing growth based on population averages."

Beyond Population Averages

The team analysed nearly 66,000 BMI data points from approximately 6,300 children and teenagers between the ages of one and 18. By tracking development over nearly two decades rather than at isolated intervals, researchers identified how genetic variations dictate specific growth rates.

"Parents often worry when a child gains weight early or grows differently from others, but our findings suggest that genetic variation can influence these changes," said co-author Geng Wang, a postdoctoral fellow at the University of Queensland.

Wang emphasised that the genetic markers influencing an infant’s size are often distinct from those that govern a teenager's frame. Consequently, early fluctuations in body size do not always serve as a definitive forecast for adult health. "Our results suggested body size differences in younger children don't necessarily reflect lifelong obesity risk," Wang observed.

Long-Term Implications

The study utilised data from the "Children of the 90s" project, a long-term health initiative based at the University of Bristol in the United Kingdom. This database has become a critical resource for scientists investigating the interplay between environmental factors and genetics.

While the research clarifies the role of heredity in development, Warrington stressed that further investigation is required to turn these insights into clinical practice. "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit," she said.

The findings come amid a global push for more personalised pediatric care, moving away from rigid "growth chart" standards toward a model that accounts for an individual child's unique genetic blueprint.

With inputs from PTI